DSM

Fortanix Surpasses Multiple Milestones, Reports Strong Growth for Fiscal Year 2024

Retrieved on: 
Wednesday, February 21, 2024
Data Management, Security, Technology, Software, Artificial Intelligence, Internet, Cloud, DSM, Engineering, International Organization (journal), SITE, Growth, PCI DSS, BYOK, Microsoft Azure, Commerce, GDPR, Software as a service, Certification, NIST, Organization, FIPS, CIS, Workforce, PCI, ISO, Google Cloud, Amazon Web Services, Fortune 500, Social Security, International Electrotechnical Commission, FINMA, IEC, OpenAI, Microsoft, AWS, Partnership, PCI-DSS, Information management, Azure, HIPAA, Format, SOC, AI, Intelligence, HSM, Confidentiality, Policy, Privacy, Amazon, Cryptocurrency

During the fiscal year ended Jan. 31, 2024, Fortanix registered strong performance in critical areas, including the largest deal in company history, record new customer acquisitions—including the company’s first customers in the Japan and MENA regions--and workforce expansion worldwide.

Key Points: 
  • During the fiscal year ended Jan. 31, 2024, Fortanix registered strong performance in critical areas, including the largest deal in company history, record new customer acquisitions—including the company’s first customers in the Japan and MENA regions--and workforce expansion worldwide.
  • Towards that end, Fortanix announced multiple new solutions and product enhancements to address important customer needs in the market.
  • The Fortanix Data Masking and Tokenization Solution, which addresses rising concerns around data breaches and expanding data privacy regulations.
  • Fortanix also formed a new partnership with DreamArts Corp. in Japan to provide BYOK to the company's SmartDB no-code/low-code development platform.

Vexcel Data Program To Expand Annual Aerial Imagery Collection Across U.S. in 2024

Retrieved on: 
Tuesday, March 5, 2024
DSM, Collection, Microsoft MapPoint, AI, Intelligence, Transport, Element, Government, Publishing, Elevate, City, DTM, Insurance, Surveying

Refreshing more areas: Vexcel will collect 4.4 million km2 of high-resolution aerial imagery, covering 93% of the U.S. population in 2024.

Key Points: 
  • Refreshing more areas: Vexcel will collect 4.4 million km2 of high-resolution aerial imagery, covering 93% of the U.S. population in 2024.
  • Meeting growing demand: The enhanced program will boost yearly collection by 15% for super-detailed aerial data in key industries, including AI.
  • CENTENNIAL, Colo., March 5, 2024 /PRNewswire/ -- Vexcel Data Program, the world's largest aerial imagery program, announced today an expansion to its annual collection in the United States for 2024.
  • This year's aerial collection covers big cities, little cities, and rural areas at an unprecedented scale, further cementing Vexcel as the largest aerial imagery program in the U.S.," said Erik Jorgensen, CEO of Vexcel Group.

Mindpath Health releases Daddy Issues: Understanding Attachment Trauma

Retrieved on: 
Wednesday, February 21, 2024
DSM, Incidence, Anxiety, Woman, Caregiver, Mental health, Emotion, Love Is Blind, Emotional dysregulation, Friends, Impulsivity, Love, Parent, Life, Risk, Perception, Dysphoria, Fear, Anhedonia, Family, Chronic pain, Hypervigilance, Child, ADHD, Trauma, DSM-IV codes, Doctor of Psychology, Personality disorder, Depression, Nursing

A psychological name for daddy issues: attachment trauma

Key Points: 
  • A psychological name for daddy issues: attachment trauma
    Clearly, 'daddy issues' is not a clinical term, and you won't find it in the DSM.
  • At its core, 'daddy issues' is a label for something very clinical: attachment trauma.
  • Like many forms of trauma, attachment trauma can have real effects on your mental health .
  • Attachment trauma, or the effects of inconsistent or abusive parenting, shows up in several different insecure attachment styles developed by psychologist John Bowlby .

Meatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food Technology

Retrieved on: 
Thursday, February 15, 2024
Technology, Retail, Food Tech, Food, Beverage, DSM, Research, Master of Science, Biotechnology, Multimedia, Chemistry, Food technology, University, Liberty Media, General partnership, TSX, McGill University, Marketing, Columbia Business School, Syngenta, MBA, Plural, Meat, Health, CAD, Mood Media, FUN Technologies, Toxicology, Science, Food security, Biology, Novozymes, Development, Head, Management

“Meatable is at an exciting juncture in our growth trajectory as we prepare to launch our consumer products in Singapore and host our first tasting in the EU.

Key Points: 
  • “Meatable is at an exciting juncture in our growth trajectory as we prepare to launch our consumer products in Singapore and host our first tasting in the EU.
  • On the Meatable Board, Mr. Abony will support the company’s management team by advising on commercial development initiatives in the U.S. as well as future transactions.
  • “Compared to others in its category, Meatable is highly differentiated through its industry-first technology and phased approach.
  • “Meatable is working at the forefront of food technology and is a clear-cut leader in the cultivated meat space,” said Ms. Malarkey.

dsm-firmenich reports full year 2023 results

Retrieved on: 
Thursday, February 15, 2024
DSM, ANH, Nutrition, Firmenich, Animal nutrition, Vitamin, Culture, Beauty, TTH, Life, Climate change, Element, Acceleration, Science, Annual, HNC, Fine chemical

2 Represents the figures on an IFRS basis, including the Firmenich results as of the merger date May 8, 2023.

Key Points: 
  • 2 Represents the figures on an IFRS basis, including the Firmenich results as of the merger date May 8, 2023.
  • We accelerated our plans for driving through additional self-help measures and advanced the review of all our business segments.
  • In Q4 2023, the program generated an about €10 million savings contribution to Adjusted EBITDA.
  • At the Annual General Meeting on May 7, 2024, dsm-firmenich's Board of Directors will propose a cash dividend of €2.50 per share for the financial year 2023.

Martin Midstream Partners Reports Fourth Quarter and Full Year 2023 Financial Results and Releases 2024 Guidance

Retrieved on: 
Wednesday, February 14, 2024
Oil, Gas, Manufacturing, Energy, Other Energy, Chemicals, Plastics, DSM, MMLP, Scotmid, Lubricant, Transport, Partnership, Conference, GAAP, Public expenditure, Legislation, USGA, Cryptocurrency

Martin Midstream Partners L.P. (Nasdaq:MMLP) (“MMLP” or the “Partnership”) today announced its financial results for the three months and year ended December 31, 2023.

Key Points: 
  • Martin Midstream Partners L.P. (Nasdaq:MMLP) (“MMLP” or the “Partnership”) today announced its financial results for the three months and year ended December 31, 2023.
  • Transportation operating income was $8.6 million and $11.1 million for the three months ended December 31, 2023 and 2022, respectively.
  • Sulfur Services operating income was $4.8 million and $9.1 million for the three months ended December 31, 2023 and 2022, respectively.
  • Specialty Products operating income (loss) was $4.0 million and $(0.9) million for the three months ended December 31, 2023 and 2022, respectively.

Corvias Foundation and National Military Family Association Support 172 Military Spouses in Career Advancement and Financial Stability

Retrieved on: 
Friday, February 9, 2024
Family, Education, Philanthropy, Defense, Military, Foundation, Other Education, Employment, Spouse, Licensure, Army, Partnership, Navy, Dream, Social work, Certification, Social, School, Multimedia, National Military Family Association, Air force, DSM, Nursing

View the full release here: https://www.businesswire.com/news/home/20240209569198/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240209569198/en/
    Corvias Foundation partnered with the National Military Family Association to invest in military spouses who are working to build their careers.
  • (Photo: Business Wire)
    Frequent moves, deployments, and other demands of military life can deeply impact many military families like Jessica’s.
  • “Here at Corvias Foundation, we are proud to support these military families and their financial strength,” said Sousa.
  • To learn more about the National Military Family Association, go to www.MilitaryFamily.org .

Medical Polymers Market Size to Grow USD 21320 Million by 2029 at a CAGR of 3.1% | Valuates Reports

Retrieved on: 
Wednesday, February 7, 2024
Polymer, Stent, Regenerative medicine, Conditional sentence, Biomaterial, Catheter, Ageing, Packaging and labeling, DSM, Polyethylene, PVC, Incidence, Tissue engineering, Biodegradable plastic, Polyvinyl chloride, Medical device, Diabetes, Administration, Risk, Cancer, Equipment, BASF

BANGALORE, India , Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).

Key Points: 
  • BANGALORE, India , Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).
  • The growing need for biocompatible materials in the healthcare industry is driving the expansion of the medical polymers market.
  • Biocompatible polymers, including polyethylene, polypropylene , and polyvinyl chloride (PVC) , find widespread application in drug delivery systems, implants, and medical devices.
  • https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-18T15867...
    The top companies in the worldwide market for medical polymers include BASF SE, Bayer, Celanese, DSM, Du Pont, and others.

Medical Polymers Market Size to Grow USD 21320 Million by 2029 at a CAGR of 3.1% | Valuates Reports

Retrieved on: 
Wednesday, February 7, 2024
Polymer, Stent, Regenerative medicine, Conditional sentence, Biomaterial, Catheter, Ageing, Packaging and labeling, DSM, Polyethylene, PVC, Incidence, Tissue engineering, Biodegradable plastic, Polyvinyl chloride, Medical device, Diabetes, Administration, Risk, Cancer, Equipment, BASF

BANGALORE, India, Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).

Key Points: 
  • BANGALORE, India, Feb. 7, 2024 /PRNewswire/ -- Medical Polymers Market is Segmented by Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), by Application (Medical Devices and Equipment, Medical Packaging).
  • The growing need for biocompatible materials in the healthcare industry is driving the expansion of the medical polymers market.
  • Biocompatible polymers, including polyethylene, polypropylene , and polyvinyl chloride (PVC) , find widespread application in drug delivery systems, implants, and medical devices.
  • https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-18T15867...
    The top companies in the worldwide market for medical polymers include BASF SE, Bayer, Celanese, DSM, Du Pont, and others.

Enable Injections Appoints David Kroekel as Chief Operating Officer

Retrieved on: 
Wednesday, February 7, 2024
Senior, Teleflex, DSM, Engineering, Mechanical, Patient, FDA, Enabling, Injection, Pennsylvania State University, Lehigh University, Enblend, U.S. FDA, Pharmaceutical industry

CINCINNATI, Feb. 7, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse® platform of wearable drug delivery systems, today announced the appointment of David Kroekel, previously Senior Vice President, Product Development and Operations at Enable, to Chief Operating Officer. In this critical position, Mr. Kroekel will play an important role leading the ongoing engineering, manufacturing, and supply of the Company's enFuse technology.

Key Points: 
  • CINCINNATI, Feb. 7, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse® platform of wearable drug delivery systems, today announced the appointment of David Kroekel, previously Senior Vice President, Product Development and Operations at Enable, to Chief Operating Officer.
  • In this critical position, Mr. Kroekel will play an important role leading the ongoing engineering, manufacturing, and supply of the Company's enFuse technology.
  • "David brings a wealth of experience in cross-functional collaboration, infrastructure development, and engineering excellence in medical device manufacturing and development," said Mike Hooven, Chairman and CEO of Enable Injections.
  • I look forward to leading and advancing how our manufacturing and product development teams increase the capabilities and efficiencies in delivering our wearable technology to more patients," said David Kroekel, Chief Operating Officer of Enable Injections.